An Observational Study of the Causes, Management, and Outcomes of Community-acquired Sepsis and Severe Sepsis in Southeast Asia
NCT02157259 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2250
Last updated 2016-02-18
Summary
This is an observational study to identify the etiology, management, and outcome of community-acquired sepsis and severe sepsis in children and adults in Southeast Asia. The study will take place in Thailand, Vietnam, and Indonesia, the partner countries of SEAICRN. Potential study patients will be any patients (both children and adults) who are presented at the hospital with community-acquired sepsis or severe sepsis and require hospitalization.
Conditions
- Sepsis
- Severe Sepsis
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
FHI 360
collaborator OTHER -
Social & Scientific Systems Inc.
collaborator INDUSTRY -
University of Oxford
lead OTHER
Principal Investigators
-
Direk Limmathurotsakul, MD · Mahidol Oxford Tropical Medicine Research Unit
Eligibility
- Min Age
- 30 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2016-02-29
- Completion
- 2016-02-29
Countries
- Indonesia
- Thailand
- Vietnam
Study Locations
More Related Trials
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
NCT06323226 ·Status: RECRUITING
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
NeoAMR Observational Study in Neonatal Sepsis
NCT03721302 ·Status: COMPLETED
-
Community Acquired Sepsis Cohort
NCT03280992 ·Status: TERMINATED
-
SEPSIS Observational Cohort Study in Young Infants in Bangladesh
NCT04012190 ·Status: COMPLETED
-
Efficacy & Safety of Resatorvid in Adults With Severe Sepsis
NCT00143611 ·Status: COMPLETED ·Phase: PHASE3
-
Severe Sepsis and Septic Shock Registry
NCT02936232 ·Status: RECRUITING
-
Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism
NCT02361970 ·Status: COMPLETED
-
Electronic Application of a Severe Sepsis Screening Tool and Management Bundle
NCT01724463 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis
NCT03356249 ·Status: COMPLETED
-
Assessing Immune Dysfunction in Sepsis
NCT07154615 ·Status: RECRUITING
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in Japan
NCT06373159 ·Status: COMPLETED
-
Gut Microbiota and Sepsis-associated Acute Kidney Injury
NCT05718804 ·Status: UNKNOWN
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
Early-Onset Sepsis an NICHD/CDC Surveillance Study
NCT02410486 ·Status: COMPLETED
-
De-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis
NCT01626612 ·Status: COMPLETED ·Phase: PHASE3
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation
NCT01362829 ·Status: COMPLETED
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis
NCT05126537 ·Status: UNKNOWN
-
Sepsis, Severe Sepsis and Septic Shock Detection by Breath Analysis
NCT03497182 ·Status: COMPLETED ·Phase: NA